注入型ドラッグデリバリーの世界市場

Future Market Insightsが発行した調査報告書(FUMI809272)
◆英語タイトル:Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
◆商品コード:FUMI809272
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2018年7月26日
◆ページ数:232
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・医薬品・医療機器
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、注入型ドラッグデリバリーの世界市場について調査・分析し、以下の構成でお届けいたします。
・注入型ドラッグデリバリーの世界市場の世界市場概観
・注入型ドラッグデリバリーの世界市場の世界市場規模
・注入型ドラッグデリバリーの世界市場の世界市場予測
・注入型ドラッグデリバリーの世界市場の世界市場:地域別市場分析
・注入型ドラッグデリバリーの世界市場のアメリカ市場規模
・注入型ドラッグデリバリーの世界市場のヨーロッパ市場規模
・注入型ドラッグデリバリーの世界市場のアジア市場規模
・注入型ドラッグデリバリーの世界市場の世界市場:セグメント別市場分析
・注入型ドラッグデリバリーの世界市場の世界市場:競争状況
・注入型ドラッグデリバリーの世界市場の世界市場:市場動向
・注入型ドラッグデリバリーの世界市場の世界市場:関連企業分析
【レポートの概要】

Report Description

This Future Market Insights (FMI) report examines the global injectable drug delivery market for the period 2018–2028. The primary objective of the report is to offer insights into market opportunity for the injectable drug delivery market.

The global injectable drug delivery market has seen substantial growth in the last decade. The market for injectable drug delivery is primarily driven by increasing prevalence of chronic diseases such as cancer, rheumatoid arthritis and diabetes. Other factors that drive the growth of the injectable drug delivery market include the need for patient-controlled delivery platforms and significant advancement in the technology. Increase in demand for point-of-care devices and the reduced dependence on healthcare provision are the other factors contributing to the growth of the injectable drug delivery market. However, stringent regulatory framework and high likelihood of premium pricing are some of the prime barriers in the growth of the injectable drug delivery market.

The Global Injectable Drug Delivery Market has been Segmented Based on:

Product Type

Usage

Distribution Channel

Regions

The report analyses the global injectable drug delivery market in terms of value. The global injectable drug delivery market report begins with the injectable drug delivery market definition and explaining different products and technologies. The injectable drug delivery market view point section includes FMI’s analysis on key trends, drivers, restraints, opportunities, trends and macro factors influencing the global injectable drug delivery market. Some of the key inclusions of injectable drug delivery report are key manufacturers and their key developments, epidemiology data and PEST analysis.

The report analyses the injectable drug delivery market based on regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

Eastern Europe

Western Europe

Latin America

Asia Pacific except Japan (APEJ)

Japan

Middle East and Africa (MEA)

Each of these sections analyse the regional injectable drug delivery market by product type, usage, distribution channel and country. The regional introductory section provides a snapshot of the regional and segmental injectable drug delivery market shares. The intensity map of the drivers and restrains in every region helps to analyse the effective regional drivers for the injectable drug delivery market.

When developing the injectable drug delivery market forecast, the starting point is sizing the current market, which forms the base for the forecast of how the injectable drug delivery market is expected to take shape in the near future. To arrive at the current market size, we have used company share analysis for the majority of the companies. The company share analysis was executed for each of the product types separately in order to arrive at the total market value. The analysis was further broken down to country level to arrive at the total regional market size of injectable drug delivery. Given the characteristics of injectable drug delivery market, we have triangulated the outcome based on different analysis based on supply side, demand side and GDP growth rate. However, quantifying the injectable drug delivery market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities, rather than rationalizing them after the forecast has been completed.

The following parameters are used to estimate the injectable drug delivery market size for the base year 2017:

Country level data for GDP and health care spending

Epidemiology of main indications of injectable drug delivery

Regional trends and opportunities

The forecast presented in the global injectable drug delivery market report provides total revenue of injectable drug delivery over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of total market revenue. The section also provides company share analysis for self-injectors market and the auto-injectors market separately. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the injectable drug delivery market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the global injectable drug delivery market report analyses the injectable drug delivery market based on product type and presents the forecast in terms of value for the next 10 years. The injectable drug delivery types covered in the report include:

Self-Injectors

Needle-free Injectors

Auto-Injectors

The next section of report analyses the market based on usage of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The usages covered in this report include:

Disposable Injectors

Reusable Injectors

The next section of report analyses the market based on distribution channel of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The distribution channels covered in this report include:

Hospital Pharmacies

Retail Pharmacies

E-commerce

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis, which helps to identify real market opportunities.

【レポートの目次】

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Injectable Drug Delivery Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Recent Developments

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

5. Global Economic Outlook

5.1. Gross Domestic Product by Region & Country, 2006 – 2021

6. Key Inclusions

6.1. Key Manufacturer List

6.2. Key Developments

6.3. PEST Analysis

7. North America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

7.1. Introduction

7.2. Regional Market Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

7.3.1. U.S.

7.3.2. Canada

7.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

7.5.1. Self-Injectors

7.5.2. Needle free Injectors

7.5.2.1. Pre Filled Needle free injectors

7.5.2.2. Fill-Able Needle Free Injectors

7.5.3. Auto Injectors

7.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

7.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

7.7.2. Reusable Injectors

7.7.2. Reusable Injectors

7.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

7.9.1. Retail Pharmacies

7.9.2. Hospital pharmacies

7.9.3. E-Commerce

7.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

7.11.Drivers and Restraints: Impact Analysis

7.12.Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Product

7.12.3. By Usage

7.12.4. By Distribution Channel

7.13.Drivers and Restraints – Impact Analysis

8. Eastern Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

8.1. Introduction

8.2. Regional Market Trends

8.3. Historical Market Size (US$ Mn) By Country, 2013–2017

8.3.1. Germany

8.3.2. France

8.3.3. U.K.

8.3.4. Spain

8.3.5. Italy

8.3.6. Rest of Western Europe

8.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

8.5.1. Self-Injectors

8.5.2. Needle free Injectors

8.5.2.1. Pre Filled Needle free injectors

8.5.2.2. Fill-Able Needle Free Injectors

8.5.3. Auto Injectors

8.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

8.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

8.7.1. Disposable Injectors

8.7.2. Reusable Injectors

8.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

8.9.1. Retail Pharmacies

8.9.2. Hospital pharmacies

8.9.3. E-Commerce

8.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

8.11.Drivers and Restraints: Impact Analysis

8.12.Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Product

8.12.3. By Usage

8.12.4. By Distribution Channel

8.13. Drivers and Restraints – Impact Analysis

9. Western Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

9.1. Introduction

9.2. Regional Market Trends

9.3. Historical Market Size (US$ Mn) By Country, 2013–2017

9.3.1. Russia

9.3.2. Poland

9.3.3. Rest of Eastern Europe

9.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

9.5.1. Self-Injectors

9.5.2. Needle free Injectors

9.5.2.1. Pre Filled Needle free injectors

9.5.2.2. Fill-Able Needle Free Injectors

9.5.3. Auto Injectors

9.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

9.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

9.7.1. Disposable Injectors

9.7.2. Reusable Injectors

9.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

9.9.1. Retail Pharmacies

9.9.2. Hospital pharmacies

9.9.3. E-Commerce

9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

9.11.Drivers and Restraints: Impact Analysis

9.12. Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Product

9.12.3. By Usage

9.12.4. By Distribution Channel

9.13. Drivers and Restraints – Impact Analysis

10. Latin America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

10.1. Introduction

10.2. Regional Market Trends

10.3. Historical Market Size (US$ Mn) By Country, 2013–2017

10.3.1. Brazil

10.3.2. Mexico

10.3.3. Rest of Latin America

10.4.Market Size (US$ Mn) Forecast By Country, 2018–2028

10.5.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

10.5.1. Self-Injectors

10.5.2. Needle free Injectors

10.5.2.1. Pre Filled Needle free injectors

10.5.2.2. Fill-Able Needle Free Injectors

10.5.3. Auto Injectors

10.6.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

10.7.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

10.7.1. Disposable Injectors

10.7.2. Reusable Injectors

10.8.Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

10.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

10.9.1. Retail Pharmacies

10.9.2. Hospital pharmacies

10.9.3. E-Commerce

10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Product

10.12.3. By Usage

10.12.4. By Distribution Channel

10.13. Drivers and Restraints – Impact Analysis

11. Asia Pacific excluding Japan and China (APEJC) Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

11.1. Introduction

11.2. Regional Market Trends

11.3. Historical Market Size (US$ Mn) By Country, 2013–2017

11.3.1. India

11.3.2. Australia and New Zealand

11.3.3. China

11.3.4. ASEAN

11.3.5. Rest of APEJ

11.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

11.5.1. Self-Injectors

11.5.2. Needle free Injectors

11.5.2.1. Pre Filled Needle free injectors

11.5.2.2. Fill-Able Needle Free Injectors

11.5.3. Auto Injectors

11.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

11.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

11.7.1. Disposable Injectors

11.7.2. Reusable Injectors

11.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

11.9.1. Retail Pharmacies

11.9.2. Hospital pharmacies

11.9.3. E-Commerce

11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

11.11. Drivers and Restraints: Impact Analysis

11.12. Market Attractiveness Analysis

11.12.1. By Country

11.12.2. By Product

11.12.3. By Usage

11.12.4. By Distribution Channel

11.13. Drivers and Restraints – Impact Analysis

12. Japan Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

12.1. Introduction

12.2. Market Trends

12.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

12.5.1. Self-Injectors

12.5.2. Needle free Injectors

12.5.2.1. Pre Filled Needle free injectors

12.5.2.2. Fill-Able Needle Free Injectors

12.5.3. Auto Injectors

12.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

12.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

12.7.1. Disposable Injectors

12.7.2. Reusable Injectors

12.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

12.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

12.9.1. Retail Pharmacies

12.9.2. Hospital pharmacies

12.9.3. E-Commerce

12.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

12.11. Drivers and Restraints: Impact Analysis

12.12. Market Attractiveness Analysis

12.12.1. By Product

12.12.2. By Usage

12.12.3. By Distribution Channel

12.13. Drivers and Restraints – Impact Analysis

13. MEA Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

13.1. Introduction

13.2. Regional Market Trends

13.3. Historical Market Size (US$ Mn) By Country, 2013–2017

13.3.1. GCC Countries

13.3.2. South Africa

13.3.3. Rest of MEA

13.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

13.5.1. Self-Injectors

13.5.2. Needle free Injectors

13.5.2.1. Pre Filled Needle free injectors

13.5.2.2. Fill-Able Needle Free Injectors

13.5.3. Auto Injectors

13.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

13.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

13.7.1. Disposable Injectors

13.7.2. Reusable Injectors

13.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

13.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

13.9.1. Retail Pharmacies

13.9.2. Hospital pharmacies

13.9.3. E-Commerce

13.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

13.11. Drivers and Restraints: Impact Analysis

13.12. Market Attractiveness Analysis

13.12.1. By Country

13.12.2. By Product

13.12.3. By Usage

13.12.4. By Distribution Channel

13.13. Drivers and Restraints – Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

16.1. Competition Dashboard

16.2. Market Share & Structure Analysis

16.3. Company Deep Dive

16.3.1. Amgen Inc.

16.3.1.1. Overview

16.3.1.2. Product and Usage Portfolio

16.3.1.3. Production Footprint

16.3.1.4. Sales Footprint

16.3.1.5. Channel Footprint

16.3.1.6. Strategy

16.3.1.6.1. Marketing Strategy

16.3.1.6.2. Product Strategy

16.3.1.6.3. Channel Strategy

16.3.2. Antares Pharma Inc.

16.3.2.1. Overview

16.3.2.2. Product and Usage Portfolio

16.3.2.3. Production Footprint

16.3.2.4. Sales Footprint

16.3.2.5. Channel Footprint

16.3.2.6. Strategy

16.3.2.6.1. Marketing Strategy

16.3.2.6.2. Product Strategy

16.3.2.6.3. Channel Strategy

16.3.3. Becton, Dickinson and Company

16.3.3.1. Overview

16.3.3.2. Product and Usage Portfolio

16.3.3.3. Production Footprint

16.3.3.4. Sales Footprint

16.3.3.5. Channel Footprint

16.3.3.6. Strategy

16.3.3.6.1. Marketing Strategy

16.3.3.6.2. Product Strategy

16.3.3.6.3. Channel Strategy

16.3.4. Consort Medical Plc (Bespak)

16.3.4.1. Overview

16.3.4.2. Product and Usage Portfolio

16.3.4.3. Production Footprint

16.3.4.4. Sales Footprint

16.3.4.5. Channel Footprint

16.3.4.6. Strategy

16.3.4.6.1. Marketing Strategy

16.3.4.6.2. Product Strategy

16.3.4.6.3. Channel Strategy

16.3.5. Crossjet

16.3.5.1. Overview

16.3.5.2. Product and Usage Portfolio

16.3.5.3. Production Footprint

16.3.5.4. Sales Footprint

16.3.5.5. Channel Footprint

16.3.5.6. Strategy

16.3.5.6.1. Marketing Strategy

16.3.5.6.2. Product Strategy

16.3.5.6.3. Channel Strategy

16.3.6. Medtronic plc

16.3.6. Overview

16.3.6.2. Product and Usage Portfolio

16.3.6.3. Production Footprint

16.3.6.4. Sales Footprint

16.3.6.5. Channel Footprint

16.3.6.6. Strategy

16.3.6.6.1. Marketing Strategy

16.3.6.6.2. Product Strategy

16.3.6.6.3. Channel Strategy

16.3.7. Mylan N.V.

16.3.7.1. Overview

16.3.7.2. Product and Usage Portfolio

16.3.7.3. Production Footprint

16.3.7.4. Sales Footprint

16.3.7.5. Channel Footprint

16.3.7.6. Strategy

16.3.7.6.1. Marketing Strategy

16.3.7.6.2. Product Strategy

16.3.7.6.3. Channel Strategy

16.3.8. SHL Group

16.3.8.1. Overview

16.3.8.2. Product and Usage Portfolio

16.3.8.3. Production Footprint

16.3.8.4. Sales Footprint

16.3.8.5. Channel Footprint

16.3.8.6. Strategy

16.3.8.6.1. Marketing Strategy

16.3.8.6.2. Product Strategy

16.3.8.6.3. Channel Strategy

16.3.9. West Pharmaceutical Services

16.3.9.1. Overview

16.3.9.2. Product and Usage Portfolio

16.3.9.3. Production Footprint

16.3.9.4. Sales Footprint

16.3.9.5. Channel Footprint

16.3.9.6. Strategy

16.3.9.6.1. Marketing Strategy

16.3.9.6.2. Product Strategy

16.3.9.6.3. Channel Strategy

16.3.10. Ypsomed

16.3.10.1. Overview

16.3.10.2. Product and Usage Portfolio

16.3.10.3. Production Footprint

16.3.10.4. Sales Footprint

16.3.10.5. Channel Footprint

16.3.10.6. Strategy

16.3.10.6.1. Marketing Strategy

16.3.10.6.2. Product Strategy

16.3.10.6.3. Channel Strategy

17. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Region

17.1.Introduction / Key Findings

17.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

17.2.1. North America

17.2.2. Western Europe

17.2.3. Eastern Europe

17.2.4. Latin America

17.2.5. Asia Pacific excluding Japan

17.2.6. Japan

17.2.7. Middle East and Africa

17.3. Market Size (US$ Mn) Forecast By Region, 2018–2028

17.4.Market Attractiveness Analysis By Region

18. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Product

18.1. Introduction

18.2.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

18.2.1. Self-Injectors

18.2.2. Needle-free Injectors

18.2.3. Auto-Injectors

18.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

18.4.Market Attractiveness Analysis By Product Type

19. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Usage

19.1. Introduction

19.2.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

19.2.1. Disposable Injectors

19.2.2. Reusable Injectors

19.3. Market Size (US$ Mn) Forecast By Usage, 2018–2028

19.4.Market Attractiveness Analysis By Usage

20. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

20.1. Introduction

20.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

20.2.1. Retail Pharmacies

20.2.2. Hospital Pharmacies

20.2.3. E-commerce

20.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

21.1.Market Value Share Analysis

21.1.1. By Country

21.1.2. By Product

21.1.3. By Usage

21.1.5. By Distribution Channel

21.2.Y-o-Y Growth Analysis

21.2.1. By Country

21.2.2. By Product

21.2.3. By Usage

21.2.5. By Distribution Channel

21.3. Absolute $ Opportunity



【レポートのキーワード】

注入型ドラッグデリバリー

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注入型ドラッグデリバリーの世界市場(Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆